Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lucas

Showing results (1351-1360 of 1,402) with videos related to

Pageof 141
Sort By:
Nature|August 17, 2018
Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicingAlberto Parras, Héctor Anta, María Santos-Galindo, et al.
JACC. Heart Failure|September 16, 2019
CORT-AHF Study: Effect on Outcomes of Systemic Corticosteroid Therapy During Early Management Acute Heart FailureÒscar Miró, Koji Takagi, Etienne Gayat, et al.
Plos Biology|March 17, 2022
Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adultsTimothy M Brown, George C Brainard, Christian Cajochen, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Plos Biology|May 7, 2025
A standardized nomenclature for the rods and cones of the vertebrate retinaTom Baden, Juan M Angueyra, Jenny M Bosten, et al.
European Heart Journal. Acute Cardiovascular Care|May 15, 2020
The CRAS-EAHFE study: Characteristics and prognosis of acute heart failure episodes with cardiorenal-anaemia syndrome at the emergency departmentLluis Llauger, Javier Jacob, Pablo Herrero-Puente, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 positionRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitorsRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Journal of Medicinal Chemistry|November 14, 1997
Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P3 positionT J Tucker, W C Lumma, S D Lewis, et al.
Plos Biology|March 12, 2024
Recommendations for measuring and standardizing light for laboratory mammals to improve welfare and reproducibility in animal researchRobert J Lucas, Annette E Allen, George C Brainard, et al.
Pageof 141

Showing results (1351-1360 of 1,402) with videos related to

Sort By:
Pageof 141
Nature|August 17, 2018
Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicingAlberto Parras, Héctor Anta, María Santos-Galindo, et al.
JACC. Heart Failure|September 16, 2019
CORT-AHF Study: Effect on Outcomes of Systemic Corticosteroid Therapy During Early Management Acute Heart FailureÒscar Miró, Koji Takagi, Etienne Gayat, et al.
Plos Biology|March 17, 2022
Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adultsTimothy M Brown, George C Brainard, Christian Cajochen, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Plos Biology|May 7, 2025
A standardized nomenclature for the rods and cones of the vertebrate retinaTom Baden, Juan M Angueyra, Jenny M Bosten, et al.
European Heart Journal. Acute Cardiovascular Care|May 15, 2020
The CRAS-EAHFE study: Characteristics and prognosis of acute heart failure episodes with cardiorenal-anaemia syndrome at the emergency departmentLluis Llauger, Javier Jacob, Pablo Herrero-Puente, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 positionRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitorsRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Journal of Medicinal Chemistry|November 14, 1997
Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P3 positionT J Tucker, W C Lumma, S D Lewis, et al.
Plos Biology|March 12, 2024
Recommendations for measuring and standardizing light for laboratory mammals to improve welfare and reproducibility in animal researchRobert J Lucas, Annette E Allen, George C Brainard, et al.
Pageof 141